Joyce J. Lee's most recent trade in RBB Bancorp was a trade of 4,442 Common Stock, No Par Value done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,442 | 51,125 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,442 | 700 | - | - | Restricted Stock Units | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 700 | 0 | - | - | Restricted Stock Units | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 700 | 46,683 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 5,347 | 45,983 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 5,347 | 700 | - | - | Restricted Stock Units | |
| Balchem Corp. | Lee Joyce J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,730 | 1,730 | - | - | Stock Option | |
| Balchem Corp. | J. Lee Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 540 | 2,776 (0%) | 0% | 0 | Common Stock | |
| RBB Bancorp | Joyce Lee Wong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 600 | 0 | - | - | Restricted Stock Units | |
| RBB Bancorp | Wong Joyce Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 600 | 40,636 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Wong Joyce Lee | Director | Purchase of securities on an exchange or from another person at price $ 18.82 per share. | 14 Dec 2023 | 5,000 | 40,036 (0%) | 0% | 18.8 | 94,100 | Common Stock, No Par Value |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 1,790 | 1,790 | - | - | Stock Option | |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 530 | 2,236 (0%) | 0% | 0 | Common Stock | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 600 | 35,036 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Joyce Wong Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 600 | 600 | - | - | Restricted Stock Units | |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,747 | 6,817 | - | - | Stock Option | |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 509 | 1,706 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.74 per share. | 30 Nov 2021 | 1,153 | 34,628 (0%) | 0% | 28.7 | 33,137 | Common Stock |
| Elanco Animal Health Inc | Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 8,492 | 35,781 (0%) | 0% | 0 | Common Stock | |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,124 | 5,070 | - | - | Stock Option | |
| Balchem Corp. | Joyce J. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 590 | 1,197 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 12,102 | 27,289 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 11,261 | 15,187 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 3,926 | 3,926 (0%) | 0% | 0 | Common Stock |